CCM
KERX

Camber Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Camber Capital Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-500,000
Closed -$4.99M – 55
2015
Q2 		$4.99M Sell
500,000
-2,500,000
-83% -$26.8M 0.4% 40
2015
Q1 		$38.2M Hold
3,000,000
– – 3.2% 15
2014
Q4 		$42.5M Sell
3,000,000
-500,000
-14% -$7.75M 3.55% 13
2014
Q3 		$48.1M Buy
3,500,000
+500,000
+17% +$7.65M 4.85% 9
2014
Q2 		$46.1M Buy
3,000,000
+1,750,000
+140% +$24.8M 3.82% 11
2014
Q1 		$21.3M Buy
+1,250,000
New +$18.9M 2.04% 21

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return